Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-κB and different signaling pathways

This publication has 30 references indexed in Scilit:

• Binding of the epstein-barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-α gene expression in monocytic cells via NF-κb involving PKC, PI3-K and tyrosine kinases
  Journal of Molecular Biology, 2000
• gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
  Annual Review of Immunology, 1997
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996
• Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.
  Journal of Clinical Investigation, 1996
• Epstein‐Barr virus/C3d receptor (CR2, CD21) activated by its extracellular ligands regulates pp105 phosphorylation through two distinct pathways
  European Journal of Immunology, 1995
• The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired Immunity
  Annual Review of Immunology, 1995
• Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoprotein
  Molecular Immunology, 1995
• The CD19/CD21 signal transduction complex of B lymphocytes
  Immunology Today, 1994
• A 16 amino acid synthetic peptide derived from human C3d triggers proliferation and specific tyrosine phosphoryiation of CR2-positive human lymphocytes and of normal resting B lymphocytes
  Biochemical and Biophysical Research Communications, 1992
• Epstein--Barr virus receptor expression on human CD8+ (cytotoxic/suppressor) T lymphocytes
  Journal of General Virology, 1990